Amgen, Horizon Deal Faces Off With FTC
Bloomberg Businessweek
00:00
AMGEN's Antitrust Complaint
The FTC is moving to block this. It'll have to go through a court challenge. AMGEN and Horizons said that they remain committed to the deal, which means that they're willing to litigate this. The complaint is not yet unsealed. So we'll see a little bit more about some of the exact allegations.
Play episode from 03:43
Transcript
